<?xml version="1.0" encoding="ISO-8859-1"?><COCHRANE_REVIEW DESCRIPTION="For publication" DOI="10.1002/14651858.CD001064" GROUP_ID="PREG" ID="350299081020101095" MERGED_FROM="" MODIFIED="2012-05-09 15:35:23 +0100" MODIFIED_BY="Sonja Henderson" NOTES="&lt;p&gt;Short title (no longer in use): Piracetam for fetal distress in labour&lt;/p&gt;&lt;p&gt;&lt;/p&gt;" NOTES_MODIFIED="2012-05-09 14:52:10 +0100" NOTES_MODIFIED_BY="Sonja Henderson" REVIEW_NO="0211" REVMAN_SUB_VERSION="5.1.6" REVMAN_VERSION="5" SPLIT_FROM="" STAGE="R" STATUS="A" TYPE="INTERVENTION" VERSION_NO="9.0">
<COVER_SHEET MODIFIED="2012-05-09 15:35:23 +0100" MODIFIED_BY="Sonja Henderson">
<TITLE>Piracetam for fetal distress in labour</TITLE>
<CONTACT MODIFIED="2012-05-09 15:35:23 +0100" MODIFIED_BY="Sonja Henderson"><PERSON ID="15917" ROLE="AUTHOR"><PREFIX>Prof</PREFIX><FIRST_NAME>G Justus</FIRST_NAME><LAST_NAME>Hofmeyr</LAST_NAME><POSITION>Director/Hon. Professor, Effective Care Research Unit</POSITION><EMAIL_1>justhof@gmail.com</EMAIL_1><ADDRESS><DEPARTMENT>Department of Obstetrics and Gynaecology, East London Hospital Complex</DEPARTMENT><ORGANISATION>University of the Witwatersrand, University of Fort Hare, Eastern Cape Department of Health</ORGANISATION><ADDRESS_1>Frere and Cecilia Makiwane Hospitals</ADDRESS_1><ADDRESS_2>Private Bag X 9047</ADDRESS_2><CITY>East London</CITY><ZIP>5200</ZIP><REGION>Eastern Cape</REGION><COUNTRY CODE="ZA">South Africa</COUNTRY><PHONE_1>+27 43 7092483</PHONE_1><PHONE_2>+27 83 2809402</PHONE_2><FAX_1>+27 43 7092483</FAX_1></ADDRESS></PERSON></CONTACT>
<CREATORS MODIFIED="2012-05-09 15:35:23 +0100" MODIFIED_BY="Sonja Henderson"><PERSON ID="15917" ROLE="AUTHOR"><PREFIX>Prof</PREFIX><FIRST_NAME>G Justus</FIRST_NAME><LAST_NAME>Hofmeyr</LAST_NAME><POSITION>Director/Hon. Professor, Effective Care Research Unit</POSITION><EMAIL_1>justhof@gmail.com</EMAIL_1><ADDRESS><DEPARTMENT>Department of Obstetrics and Gynaecology, East London Hospital Complex</DEPARTMENT><ORGANISATION>University of the Witwatersrand, University of Fort Hare, Eastern Cape Department of Health</ORGANISATION><ADDRESS_1>Frere and Cecilia Makiwane Hospitals</ADDRESS_1><ADDRESS_2>Private Bag X 9047</ADDRESS_2><CITY>East London</CITY><ZIP>5200</ZIP><REGION>Eastern Cape</REGION><COUNTRY CODE="ZA">South Africa</COUNTRY><PHONE_1>+27 43 7092483</PHONE_1><PHONE_2>+27 83 2809402</PHONE_2><FAX_1>+27 43 7092483</FAX_1></ADDRESS></PERSON><PERSON ID="5770" ROLE="AUTHOR"><PREFIX>Dr</PREFIX><FIRST_NAME>Regina</FIRST_NAME><LAST_NAME>Kulier</LAST_NAME><EMAIL_1>regina.kulier@gmail.com</EMAIL_1><ADDRESS><ORGANISATION/><CITY>Geneva</CITY><COUNTRY CODE="CH">Switzerland</COUNTRY><PHONE_1>+ 41 22 7912744</PHONE_1></ADDRESS></PERSON></CREATORS>
<DATES MODIFIED="2012-05-09 14:52:10 +0100" MODIFIED_BY="[Empty name]">
<UP_TO_DATE>
<DATE DAY="9" MONTH="5" YEAR="2012"/>
</UP_TO_DATE>
<LAST_SEARCH>
<DATE DAY="15" MONTH="2" YEAR="2012"/>
</LAST_SEARCH>
<NEXT_STAGE>
<DATE DAY="2" MONTH="12" YEAR="2013"/>
</NEXT_STAGE>
<PROTOCOL_PUBLISHED ISSUE="2" YEAR="1998"/>
<REVIEW_PUBLISHED ISSUE="2" YEAR="1998"/>
<LAST_CITATION_ISSUE ISSUE="2" YEAR="1998"/>
</DATES>
<WHATS_NEW MODIFIED="2012-02-17 12:26:18 +0000" MODIFIED_BY="[Empty name]">
<WHATS_NEW_ENTRY EVENT="NEW_CITATION_OLD_CONCLUSIONS" MODIFIED="2012-02-17 12:26:18 +0000" MODIFIED_BY="[Empty name]">
<DATE DAY="17" MONTH="2" YEAR="2012"/>
<DESCRIPTION>
<P>Review updated.</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
<WHATS_NEW_ENTRY EVENT="UPDATE" MODIFIED="2012-02-17 12:26:05 +0000" MODIFIED_BY="[Empty name]">
<DATE DAY="17" MONTH="2" YEAR="2012"/>
<DESCRIPTION>
<P>Search updated. No new trials identified.</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
</WHATS_NEW>
<HISTORY MODIFIED="2012-02-17 12:25:52 +0000" MODIFIED_BY="[Empty name]">
<WHATS_NEW_ENTRY EVENT="AMENDMENT" MODIFIED="2012-02-17 12:25:52 +0000" MODIFIED_BY="[Empty name]">
<DATE DAY="2" MONTH="7" YEAR="2010"/>
<DESCRIPTION>
<P>Contact details edited.</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
<WHATS_NEW_ENTRY EVENT="UPDATE" MODIFIED="2010-07-02 11:47:17 +0100" MODIFIED_BY="[Empty name]">
<DATE DAY="24" MONTH="6" YEAR="2009"/>
<DESCRIPTION>
<P>Search updated. No new trials identified. Plain language summary added.</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
<WHATS_NEW_ENTRY EVENT="AMENDMENT" MODIFIED="2009-06-24 10:57:34 +0100" MODIFIED_BY="[Empty name]">
<DATE DAY="20" MONTH="9" YEAR="2008"/>
<DESCRIPTION>
<P>Converted to new review format.</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
<WHATS_NEW_ENTRY EVENT="UPDATE" MODIFIED="2008-10-29 13:23:01 +0000" MODIFIED_BY="[Empty name]">
<DATE DAY="25" MONTH="10" YEAR="2004"/>
<DESCRIPTION>
<P>Search updated. No new trials identified.</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
<WHATS_NEW_ENTRY EVENT="UPDATE" MODIFIED="2008-10-29 13:23:03 +0000" MODIFIED_BY="[Empty name]">
<DATE DAY="30" MONTH="9" YEAR="2001"/>
<DESCRIPTION>
<P>One study (<LINK REF="STD-Klink-1979" TYPE="STUDY">Klink 1979</LINK>) was evaluated and not included in the review.</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
</HISTORY>
<SOURCES_OF_SUPPORT>
<INTERNAL_SOURCES>
<SOURCE>
<NAME>University of the Witwatersrand</NAME>
<COUNTRY CODE="ZA">South Africa</COUNTRY>
<DESCRIPTION/>
</SOURCE>
<SOURCE>
<NAME>Department of Obstetrics and Gynaecology, Geneva University Hospital</NAME>
<COUNTRY CODE="CH">Switzerland</COUNTRY>
<DESCRIPTION/>
</SOURCE>
</INTERNAL_SOURCES>
<EXTERNAL_SOURCES>
<SOURCE>
<NAME>South African Medical Research Council</NAME>
<COUNTRY CODE="ZA">South Africa</COUNTRY>
<DESCRIPTION/>
</SOURCE>
<SOURCE>
<NAME>The Nuffield Trust</NAME>
<COUNTRY CODE="GB">UK</COUNTRY>
<DESCRIPTION/>
</SOURCE>
</EXTERNAL_SOURCES>
</SOURCES_OF_SUPPORT>
<MESH_TERMS VERIFIED="NO"/>
<KEYWORDS/>
</COVER_SHEET>
<MAIN_TEXT MODIFIED="2012-02-15 12:51:49 +0000" MODIFIED_BY="[Empty name]">
<SUMMARY MODIFIED="2009-07-20 14:28:44 +0100" MODIFIED_BY="[Empty name]">
<TITLE MODIFIED="2008-09-21 12:50:35 +0100" MODIFIED_BY="[Empty name]">Piracetam for fetal distress in labour</TITLE>
<SUMMARY_BODY MODIFIED="2009-07-20 14:28:44 +0100" MODIFIED_BY="[Empty name]">
<P>Piracetam is thought to support the metabolism of brain cells when they have an insufficient oxygen supply (hypoxia). It may, therefore, prevent any adverse effects for an infant with persistent fetal distress during labour.</P>
<P>This review set out to assess the effects of piracetam for suspected fetal distress in labour on method of delivery and newborn ill effects (morbidity). Only one controlled trial was identified. The trial randomised 96 women to receive either piracetam or a placebo. Piracetam treatment was associated with a trend toward reduced need for a caesarean section as the method of delivery and an improved outcome for the newborn as determined by respiratory problems and signs of hypoxia. The trial did not provide information about any side effects experienced by the mother. This evidence is insufficient for meaningful conclusions.</P>
</SUMMARY_BODY>
</SUMMARY>
<ABSTRACT MODIFIED="2012-02-15 12:51:05 +0000" MODIFIED_BY="[Empty name]">
<ABS_BACKGROUND>
<P>Piracetam is thought to promote the metabolism of brain cells when they are hypoxic. It has been used to prevent adverse effects of fetal distress. </P>
</ABS_BACKGROUND>
<ABS_OBJECTIVES>
<P>The objective of this review was to assess the effects of piracetam for suspected fetal distress in labour on method of delivery and perinatal morbidity.</P>
</ABS_OBJECTIVES>
<ABS_SEARCH_STRATEGY MODIFIED="2012-02-15 12:51:05 +0000" MODIFIED_BY="[Empty name]">
<P>We searched the Cochrane Pregnancy and Childbirth Group's Trials Register (15 February 2012).</P>
</ABS_SEARCH_STRATEGY>
<ABS_SELECTION_CRITERIA>
<P>Randomised trials of piracetam compared with placebo or no treatment for suspected fetal distress in labour.</P>
</ABS_SELECTION_CRITERIA>
<ABS_DATA_COLLECTION MODIFIED="2009-07-03 14:40:18 +0100" MODIFIED_BY="[Empty name]">
<P>Both review authors assessed eligibility and trial quality.</P>
</ABS_DATA_COLLECTION>
<ABS_RESULTS MODIFIED="2009-07-15 12:36:45 +0100" MODIFIED_BY="[Empty name]">
<P>One study of 96 women was included. Piracetam compared with placebo was associated with a trend to reduced need for caesarean section (risk ratio 0.57, 95% confidence interval 0.32 to 1.03). There were no statistically significant differences between the piracetam and placebo group for neonatal morbidity (measured by neonatal respiratory distress) or Apgar score.</P>
</ABS_RESULTS>
<ABS_CONCLUSIONS>
<P>There is not enough evidence to evaluate the use of piracetam for fetal distress in labour.</P>
</ABS_CONCLUSIONS>
</ABSTRACT>
<BODY MODIFIED="2012-02-15 12:51:49 +0000" MODIFIED_BY="[Empty name]">
<BACKGROUND MODIFIED="2009-07-15 12:41:23 +0100" MODIFIED_BY="[Empty name]">
<P>Piracetam, a derivative of gamma-aminobenzoic acid, is thought to promote the metabolism of the brain cells when they are hypoxic. It has therefore, been considered as a possible intervention for ameliorating the effects of perinatal asphyxia (<LINK REF="REF-Margaria-Mutani-1974" TYPE="REFERENCE">Margaria Mutani 1974</LINK>). Its use in persistent intrapartum fetal distress to 'treat' the fetus to prevent any adverse effects has been evaluated in a single placebo-controlled trial (<LINK REF="STD-Huaman-1983" TYPE="STUDY">Huaman 1983</LINK>).</P>
<P>For further information <I>see</I> <LINK REF="REF-Grant-1989" TYPE="REFERENCE">Grant 1989</LINK>.</P>
</BACKGROUND>
<OBJECTIVES>
<P>To determine, from the best available evidence, the effects on method of delivery and perinatal morbidity of piracetam treatment for suspected fetal distress in labour.</P>
</OBJECTIVES>
<METHODS MODIFIED="2012-02-15 12:51:49 +0000" MODIFIED_BY="[Empty name]">
<SELECTION_CRITERIA>
<CRIT_STUDIES>
<P>Clinical trials comparing effects of piracetam treatment for suspected fetal distress in labour with placebo or no treatment; random allocation to treatment and control groups, with adequate allocation concealment; violations of allocated management and exclusions after allocation not sufficient to materially affect outcomes.</P>
</CRIT_STUDIES>
<CRIT_PARTICIPANTS>
<P>Women with suspected fetal distress in labour.</P>
</CRIT_PARTICIPANTS>
<CRIT_INTERVENTIONS>
<P>Piracetam versus placebo or no treatment.</P>
</CRIT_INTERVENTIONS>
<CRIT_OUTCOMES>
<P>Method of delivery; measures of perinatal morbidity and mortality; side effects for women.<BR/>Outcomes included if clinically meaningful; reasonable measures taken to minimise observer bias; missing data insufficient to materially influence conclusions; data available for analysis according to original allocation, irrespective of protocol violations; data available in format suitable for analysis.</P>
</CRIT_OUTCOMES>
</SELECTION_CRITERIA>
<SEARCH_METHODS MODIFIED="2012-02-15 12:51:49 +0000" MODIFIED_BY="[Empty name]">
<ELECTRONIC_SEARCHES MODIFIED="2012-02-15 12:51:49 +0000" MODIFIED_BY="[Empty name]">
<P>We searched the Cochrane Pregnancy and Childbirth Group&#8217;s Trials Register by contacting the Trials Search Co-ordinator (15 February 2012). </P>
<P>The Cochrane Pregnancy and Childbirth Group&#8217;s Trials Register is maintained by the Trials Search Co-ordinator and contains trials identified from: </P>
<OL>
<LI>quarterly searches of the Cochrane Central Register of Controlled Trials (CENTRAL);</LI>
<LI>weekly searches of MEDLINE;</LI>
<LI>weekly searches of EMBASE;</LI>
<LI>handsearches of 30 journals and the proceedings of major conferences;</LI>
<LI>weekly current awareness alerts for a further 44 journals plus monthly BioMed Central email alerts.</LI>
</OL>
<P>Details of the search strategies for CENTRAL, MEDLINE and EMBASE, the list of handsearched journals and conference proceedings, and the list of journals reviewed via the current awareness service can be found in the &#8216;Specialized Register&#8217; section within the editorial information about the <A HREF="http://www.mrw.interscience.wiley.com/cochrane/clabout/articles/PREG/frame.html">Cochrane Pregnancy and Childbirth Group</A>. </P>
<P>Trials identified through the searching activities described above are each assigned to a review topic (or topics). The Trials Search Co-ordinator searches the register for each review using the topic list rather than keywords.  </P>
<P>We did not apply any language restrictions. </P>
</ELECTRONIC_SEARCHES>
</SEARCH_METHODS>
<DATA_COLLECTION MODIFIED="2009-07-03 14:41:48 +0100" MODIFIED_BY="[Empty name]">
<P>The trial under consideration was evaluated for methodological quality and appropriateness for inclusion according to the prestated selection criteria, without consideration of the results. Individual outcome data were included in the analysis if they met the prestated criteria in 'Types of outcome measures'. Included trial data were processed as described in <LINK REF="REF-Clarke-2000" TYPE="REFERENCE">Clarke 2000</LINK>.</P>
<P>Data were extracted from the source and entered onto the Review Manager (RevMan) computer software (<LINK REF="REF-RevMan-2000" TYPE="REFERENCE">RevMan 2000</LINK>), checked for accuracy, and analysed as above using the RevMan software. For dichotomous data, risk ratios and 95% confidence intervals were calculated.</P>
</DATA_COLLECTION>
</METHODS>
<RESULTS MODIFIED="2009-07-03 14:42:47 +0100" MODIFIED_BY="[Empty name]">
<STUDY_DESCRIPTION MODIFIED="2009-07-03 14:42:09 +0100" MODIFIED_BY="[Empty name]">
<P>
<I>See</I> table of '<LINK TAG="CHARACTERISTICS_OF_INCLUDED_STUDIES" TYPE="SECTION">Characteristics of included studies</LINK>'.</P>
</STUDY_DESCRIPTION>
<STUDY_QUALITY MODIFIED="2009-07-03 14:42:29 +0100" MODIFIED_BY="[Empty name]">
<P>
<I>See</I> table of '<LINK TAG="CHARACTERISTICS_OF_INCLUDED_STUDIES" TYPE="SECTION">Characteristics of included studies</LINK>', particularly the 'Methods' and 'Notes' sections.</P>
<P>In the double-blind placebo-controlled study of Huaman et al (<LINK REF="STD-Huaman-1983" TYPE="STUDY">Huaman 1983</LINK>), some selection bias may have been introduced by the exclusion of two participants who delivered shortly after enrolment and two with infection-related fetal malformations, but the number excluded is relatively small in relation to the 96 women studied. Whether or not the subjective outcomes such as Apgar score and neurological examination were recorded blind to the allocation of each baby is not specified.</P>
</STUDY_QUALITY>
<INTERVENTION_EFFECTS MODIFIED="2009-07-03 14:42:47 +0100" MODIFIED_BY="[Empty name]">
<P>Piracetam treatment was associated with a trend to reduced need for caesarean section (risk ratio (RR) 0.57, 95% confidence interval (CI) 0.32 to 1.03), and improved neonatal outcome as judged by neonatal respiratory problems and signs of hypoxia (RR 0.09, 95% CI 0.01 to 1.60). The Apgar score results are consistent with anything from a large beneficial to a small adverse effect. No information is available on maternal side effects.</P>
</INTERVENTION_EFFECTS>
</RESULTS>
<DISCUSSION>
<P>Only one trial has been reviewed, and the evidence is insufficient for meaningful conclusions.</P>
</DISCUSSION>
<CONCLUSIONS>
<IMPLICATIONS_PRACTICE>
<P>There is insufficient evidence to support the use of piracetam for fetal distress in labour.</P>
</IMPLICATIONS_PRACTICE>
<IMPLICATIONS_RESEARCH>
<P>Because only one randomized trial of piracetam for fetal distress has, to our knowledge, been reported, there is scope for further trials of this intervention.</P>
</IMPLICATIONS_RESEARCH>
</CONCLUSIONS>
</BODY>
<ACKNOWLEDGEMENTS>
<P>None.</P>
</ACKNOWLEDGEMENTS>
<CONFLICT_OF_INTEREST>
<P>None known.<BR/> </P>
</CONFLICT_OF_INTEREST>
<CONTRIBUTIONS>
<P>GJ Hofmeyr prepared the original version, and is responsible for maintaining the review. R Kulier quality-checked and revised the review.</P>
</CONTRIBUTIONS>
<PRO_REV_DIFF/>
<PUBLIC_NOTES/>
</MAIN_TEXT>
<STUDIES_AND_REFERENCES MODIFIED="2009-07-15 12:46:09 +0100" MODIFIED_BY="[Empty name]">
<STUDIES>
<INCLUDED_STUDIES>
<STUDY DATA_SOURCE="PUB" ID="STD-Huaman-1983" NAME="Huaman 1983" YEAR="1983">
<REFERENCE NOTES="&lt;p&gt;[2287]&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Huaman EJ, Hassoun R, Itahashi CM, Pereda GJ, Mejia MA</AU>
<TI>Results obtained with piracetam in foetal distress during labour</TI>
<SO>Journal of International Medical Research</SO>
<YR>1983</YR>
<VL>11</VL>
<PG>129-36</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
</INCLUDED_STUDIES>
<EXCLUDED_STUDIES>
<STUDY DATA_SOURCE="PUB" ID="STD-Klink-1979" NAME="Klink 1979" YEAR="1979">
<REFERENCE NOTES="&lt;p&gt;Klink F, Grosspietzsch R, von Klitzing L, Oberheuser F. The protective effect of piracetam during delivery [translation]. Fortschritte der Medizin 1979;97:2163-5&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Klink F, Grosspietzsch R, von Klitzing L, Oberheuser F</AU>
<TI>[The protective effect of piracetam during delivery]</TI>
<TO>Zur protektiven wirkung von piracetam unter der geburt</TO>
<SO>Fortschritte der Medizin</SO>
<YR>1979</YR>
<VL>97</VL>
<PG>2163-5</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
</EXCLUDED_STUDIES>
<AWAITING_STUDIES/>
<ONGOING_STUDIES/>
</STUDIES>
<OTHER_REFERENCES MODIFIED="2009-07-15 12:46:09 +0100" MODIFIED_BY="[Empty name]">
<ADDITIONAL_REFERENCES MODIFIED="2009-07-15 12:46:09 +0100" MODIFIED_BY="[Empty name]">
<REFERENCE ID="REF-Clarke-2000" MODIFIED="2009-06-24 11:03:07 +0100" MODIFIED_BY="[Empty name]" NAME="Clarke 2000" TYPE="OTHER">
<AU>Clarke M, Oxman AD, editors</AU>
<TI>Cochrane Reviewers&#8217; Handbook 4.1 [updated July 2000]</TI>
<SO>In: Review Manager (RevMan) [Computer program]. Version 4.1. Oxford, England: The Cochrane Collaboration, 2000</SO>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Grant-1989" MODIFIED="2009-06-24 11:02:33 +0100" MODIFIED_BY="[Empty name]" NAME="Grant 1989" TYPE="BOOK_SECTION">
<AU>Grant AM</AU>
<TI>Monitoring the fetus during labour</TI>
<SO>Effective care in pregnancy and childbirth</SO>
<YR>1989</YR>
<PG>846-82</PG>
<ED>Chalmers I, Enkin MW, Keirse MJNC</ED>
<PB>Oxford University Press</PB>
<CY>Oxford</CY>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Margaria-Mutani-1974" MODIFIED="2009-07-15 12:46:09 +0100" MODIFIED_BY="[Empty name]" NAME="Margaria Mutani 1974" TYPE="JOURNAL_ARTICLE">
<AU>Margaria Mutani E</AU>
<TI>Preliminary experimental and clinical trials of prevention and therapy of perinatal distress with piracetam</TI>
<SO>Anesthesie, Analgesie, Reanimation</SO>
<YR>1974</YR>
<VL>3</VL>
<PG>397-408</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-RevMan-2000" NAME="RevMan 2000" TYPE="COMPUTER_PROGRAM">
<TI>Review Manager (RevMan)</TI>
<YR>2000</YR>
<EN>4.1 for Windows</EN>
<PB>The Cochrane Collaboration</PB>
<CY>Oxford, England</CY>
<IDENTIFIERS/>
</REFERENCE>
</ADDITIONAL_REFERENCES>
<OTHER_VERSIONS_REFERENCES MODIFIED="2009-06-24 11:02:48 +0100" MODIFIED_BY="[Empty name]">
<REFERENCE ID="REF-Hofmeyr-1995" MODIFIED="2009-06-24 11:02:48 +0100" MODIFIED_BY="[Empty name]" NAME="Hofmeyr 1995" TYPE="OTHER">
<AU>Hofmeyr GJ</AU>
<TI>Piracetam for fetal distress in labour. [revised 24 March 1993]</TI>
<SO>In: Enkin MW, Keirse MJNC, Renfrew MJ, Neilson JP, Crowther C (eds.) Pregnancy and Childbirth Module. In: The Cochrane Pregnancy and Childbirth Database [database on disk and CDROM]. The Cochrane Collaboration; Issue 2, Oxford: Update Software; 1995</SO>
<IDENTIFIERS/>
</REFERENCE>
</OTHER_VERSIONS_REFERENCES>
<PENDING_REFERENCES/>
</OTHER_REFERENCES>
</STUDIES_AND_REFERENCES>
<CHARACTERISTICS_OF_STUDIES MODIFIED="2012-02-17 12:26:35 +0000" MODIFIED_BY="[Empty name]">
<CHARACTERISTICS_OF_INCLUDED_STUDIES MODIFIED="2012-02-17 12:26:35 +0000" MODIFIED_BY="[Empty name]" SORT_BY="STUDY" USER_DEF_1_ENABLED="NO" USER_DEF_2_ENABLED="NO" USER_DEF_3_ENABLED="NO">
<INCLUDED_CHAR MODIFIED="2009-07-03 14:43:34 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Huaman-1983">
<CHAR_METHODS>
<P>Double-blind placebo- controlled randomised study.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS>
<P>Women with diagnosis of acute fetal distress (meconium stained amniotic fluid and/or pathological fetal heart rate pattern).</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS>
<P>Piracetam (n = 48) versus placebo (n = 48), intravenously 6 ampoules at once and 2 ampoules hourly.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>Time to delivery; Apgar scores; morbidity on clinical and neurological assessment at 24 hours (respiratory difficulties, signs of slight to severe hypoxia); placental histology.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2009-07-03 14:43:34 +0100" MODIFIED_BY="[Empty name]">
<P>Lima, Peru.</P>
<P>Some selection bias may have been introduced by the exclusion of 2 participants who delivered shortly after enrolment and 2 with infection-related fetal malformations, but the number excluded is relatively small in relation to the number studied. Whether or not the subjective outcomes such as Apgar score and neurological examination were recorded blind to the allocation of each baby is not specified.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<FOOTNOTES/>
</CHARACTERISTICS_OF_INCLUDED_STUDIES>
<CHARACTERISTICS_OF_EXCLUDED_STUDIES MODIFIED="2009-07-03 14:44:58 +0100" MODIFIED_BY="[Empty name]" SORT_BY="STUDY">
<EXCLUDED_CHAR STUDY_ID="STD-Klink-1979">
<CHAR_REASON_FOR_EXCLUSION>
<P>Excluded because healthy fetuses were studied, not compromised fetuses. Piracetam was administered to 17 nulliparous women during labour (10 g i.v./h), and placebo to 9 women. Following piracetam, fetal EEG showed an activation of alpha-waves with reduction of delta-waves, CTG showed reduced decelerations during the expulsion period and Apgar scores were better than 9 in all cases.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<FOOTNOTES>
<P>CTG: cardiotocograph<BR/>EEG: electroencephalography<BR/>i.v.: intravenous</P>
</FOOTNOTES>
</CHARACTERISTICS_OF_EXCLUDED_STUDIES>
<CHARACTERISTICS_OF_AWAITING_STUDIES SORT_BY="STUDY" USER_DEF_1_ENABLED="NO" USER_DEF_2_ENABLED="NO" USER_DEF_3_ENABLED="NO">
<FOOTNOTES/>
</CHARACTERISTICS_OF_AWAITING_STUDIES>
<CHARACTERISTICS_OF_ONGOING_STUDIES SORT_BY="STUDY" USER_DEF_1_ENABLED="NO" USER_DEF_2_ENABLED="NO" USER_DEF_3_ENABLED="NO">
<FOOTNOTES/>
</CHARACTERISTICS_OF_ONGOING_STUDIES>
</CHARACTERISTICS_OF_STUDIES>
<QUALITY_ITEMS MODIFIED="2012-02-17 12:26:35 +0000" MODIFIED_BY="[Empty name]">
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-01" LEVEL="STUDY" NO="1">
<NAME>Random sequence generation (selection bias)</NAME>
<DESCRIPTION>
<P>Selection bias (biased allocation to interventions) due to inadequate generation of a randomised sequence</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-02" LEVEL="STUDY" MODIFIED="2012-02-17 12:26:35 +0000" MODIFIED_BY="[Empty name]" NO="2">
<NAME>Allocation concealment (selection bias)</NAME>
<DESCRIPTION>
<P>Selection bias (biased allocation to interventions) due to inadequate concealment of allocations prior to assignment</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-02-17 12:26:35 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Huaman-1983">
<DESCRIPTION>
<P>Adequate</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-03" LEVEL="GROUP" NO="3">
<NAME>Blinding (performance bias and detection bias)</NAME>
<DESCRIPTION>
<P>Performance bias or detection bias due to knowledge of the allocated interventions after assignment</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="NO" ID="QIT-07" LEVEL="GROUP" NO="7">
<NAME>Blinding of participants and personnel (performance bias)</NAME>
<DESCRIPTION>
<P>Performance bias due to knowledge of the allocated interventions by participants and personnel during the study</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="NO" ID="QIT-08" LEVEL="GROUP" NO="8">
<NAME>Blinding of outcome assessment (detection bias)</NAME>
<DESCRIPTION>
<P>Detection bias due to knowledge of the allocated interventions by outcome assessors</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-04" LEVEL="GROUP" NO="4">
<NAME>Incomplete outcome data (attrition bias)</NAME>
<DESCRIPTION>
<P>Attrition bias due to amount, nature or handling of incomplete outcome data</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-05" LEVEL="STUDY" NO="5">
<NAME>Selective reporting (reporting bias)</NAME>
<DESCRIPTION>
<P>Reporting bias due to selective outcome reporting</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-06" LEVEL="STUDY" NO="6">
<NAME>Other bias</NAME>
<DESCRIPTION>
<P>Bias due to problems not covered elsewhere in the table</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
</QUALITY_ITEMS>
<SOF_TABLES/>
<ADDITIONAL_TABLES/>
<ANALYSES_AND_DATA CALCULATED_DATA="YES" MODIFIED="2009-07-03 14:45:27 +0100" MODIFIED_BY="[Empty name]">
<COMPARISON ID="CMP-001" MODIFIED="2009-07-03 14:45:27 +0100" MODIFIED_BY="[Empty name]" NO="1">
<NAME>Piracetam for fetal distress in labour</NAME>
<DICH_OUTCOME CHI2="0.0" CI_END="1.026377352366531" CI_START="0.318138949083407" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.5714285714285714" ESTIMABLE="YES" EVENTS_1="12" EVENTS_2="21" I2="0.0" I2_Q="0.0" ID="CMP-001.01" LOG_CI_END="0.011307060503701038" LOG_CI_START="-0.49738315787629" LOG_EFFECT_SIZE="-0.24303804868629447" METHOD="MH" NO="1" P_CHI2="1.0" P_Q="1.0" P_Z="0.061091499224873905" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="48" TOTAL_2="48" WEIGHT="100.0" Z="1.8728326399317539">
<NAME>Caesarean section</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1/>
<GRAPH_LABEL_2/>
<DICH_DATA CI_END="1.026377352366531" CI_START="0.318138949083407" EFFECT_SIZE="0.5714285714285714" ESTIMABLE="YES" EVENTS_1="12" EVENTS_2="21" LOG_CI_END="0.011307060503701038" LOG_CI_START="-0.49738315787629" LOG_EFFECT_SIZE="-0.24303804868629447" ORDER="14433" O_E="0.0" SE="0.2988071523335984" STUDY_ID="STD-Huaman-1983" TOTAL_1="48" TOTAL_2="48" VAR="0.08928571428571427" WEIGHT="100.0"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="1.962030307151412" CI_START="0.08154817966716182" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.4" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="5" I2="0.0" I2_Q="0.0" ID="CMP-001.02" LOG_CI_END="0.29270571156939484" LOG_CI_START="-1.08858572891347" LOG_EFFECT_SIZE="-0.3979400086720376" METHOD="MH" MODIFIED="2009-07-03 14:45:21 +0100" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="1.0" P_Q="1.0" P_Z="0.25877017578365735" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="48" TOTAL_2="48" WEIGHT="100.0" Z="1.129302712151898">
<NAME>Apgar score &lt; 7 at 1 minute</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1/>
<GRAPH_LABEL_2/>
<DICH_DATA CI_END="1.9620303071514118" CI_START="0.08154817966716182" EFFECT_SIZE="0.4" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="5" LOG_CI_END="0.2927057115693948" LOG_CI_START="-1.08858572891347" LOG_EFFECT_SIZE="-0.3979400086720376" ORDER="14434" O_E="0.0" SE="0.8113774296425389" STUDY_ID="STD-Huaman-1983" TOTAL_1="48" TOTAL_2="48" VAR="0.6583333333333332" WEIGHT="100.0"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="1.5999236664926908" CI_START="0.005165535695858843" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.09090909090909091" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="5" I2="0.0" I2_Q="0.0" ID="CMP-001.03" LOG_CI_END="0.20409926264853076" LOG_CI_START="-2.286884632964981" LOG_EFFECT_SIZE="-1.041392685158225" METHOD="MH" MODIFIED="2009-07-03 14:45:27 +0100" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="1.0" P_Q="1.0" P_Z="0.10125827253200181" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="48" TOTAL_2="48" WEIGHT="100.00000000000001" Z="1.6387839040371432">
<NAME>Neonatal morbidity</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1/>
<GRAPH_LABEL_2/>
<DICH_DATA CI_END="1.5999236664926908" CI_START="0.005165535695858843" EFFECT_SIZE="0.09090909090909091" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="5" LOG_CI_END="0.20409926264853076" LOG_CI_START="-2.286884632964981" LOG_EFFECT_SIZE="-1.041392685158225" ORDER="14435" O_E="0.0" SE="1.463216270852525" STUDY_ID="STD-Huaman-1983" TOTAL_1="48" TOTAL_2="48" VAR="2.14100185528757" WEIGHT="100.00000000000001"/>
</DICH_OUTCOME>
</COMPARISON>
</ANALYSES_AND_DATA>
<FIGURES/>
<FEEDBACK/>
<APPENDICES/>
<EXTENSIONS/>
</COCHRANE_REVIEW>